Invasive Aspergillosis: New Insights into Disease, Diagnostic and Treatment
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
3569-3594
Author(s):
Meinolf Karthaus and Dieter Buchheidt
Dissecting Bortezomib: Development, Application, Adverse Effects and Future Direction
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
3190-3200
Author(s):
Biyin Cao, Jie Li and Xinliang Mao
Oleocanthal Inhibits Proliferation and MIP-1α Expression in Human Multiple Myeloma Cells
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
2467-2475
Author(s):
M. Scotece, R. Gomez, J. Conde, V. Lopez, J.J. Gomez-Reino, F. Lago, A.B. Smith III and O. Gualillo
Emerging Role of the Ubiquitin-proteasome System as Drug Targets
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
3175-3189
Author(s):
Gozde Kar, Ozlem Keskin, Franca Fraternali and Attila Gursoy
Undressing the Fungal Cell Wall/Cell Membrane - the Antifungal Drug Targets
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
3738-3747
Author(s):
Rui Tada, Jean-Paul Latge and Vishukumar Aimanianda
TRAIL-Based Therapeutic Approaches for the Treatment of Pediatric Malignancies
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
2254-2271
Author(s):
C. Gasparini, L. Vecchi Brumatti, L. Monasta and G. Zauli
New Insights into Invasive Aspergillosis - from the Pathogen to the Disease
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
3679-3688
Author(s):
Ulrike Binder and Cornelia Lass-Florl
Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
3248-3262
Author(s):
Tiffany DeVine and Mu-Shui Dai
Pharmacodynamics and Pharmacokinetics of Antifungals for Treatment of Invasive Aspergillosis
Journal:
Current Pharmaceutical Design
Volume:
19
Page:
3629-3647
Author(s):
Romuald Bellmann
Mitochondria in Cancer Stem Cells: A Target for Therapy
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
7
Page:
102-114
Author(s):
Rute Loureiro, Katia A. Mesquita, Paulo J. Oliveira and Ignacio Vega-Naredo